Welcure Drugs (WELCURE) | Financial Analysis & Statements

Welcure Drugs & Pharmaceuticals Ltd. | Small-cap | Healthcare

₹12.96

4.94%

| Welcure Drugs Stock Comparison:

No comparison data available

Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 245.5M

Gross Profit 40.5M 16.48%

Operating Income 8.7M 3.54%

Net Income 21.7M 8.84%

Balance Sheet Metrics

Total Assets 2.7B

Total Liabilities 1.6B

Shareholders Equity 1.0B

Debt to Equity 1.60

Cash Flow Metrics

Operating Cash Flow -2.2B

Free Cash Flow -2.2B

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Welcure Drugs Income Statement From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Revenue	245.5M	0	0	1.0M	1.3M
Cost of Goods Sold	205.0M	0	0	0	0
Gross Profit	40.5M	0	0	0	0
Operating Expenses	28.9M	1.1M	899.0K	661.1K	679.8K
Operating Income	8.7M	-2.7M	-1.4M	236.5K	550.2K
Pre-tax Income	27.8M	-1.7M	1.0M	235.8K	551.5K
Income Tax	6.1M	0	0	0	0
Net Income	21.7M	-1.7M	1.0M	235.8K	551.5K
EPS (Diluted)	-	-₹0.13	₹0.08	₹0.02	₹0.05

Income Statement Trend

Welcure Drugs Balance Sheet From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Assets
Current Assets	1.8B	318.0K	59.0K	660.1K	474.6K
Non-Current Assets	848.4M	13.4M	15.2M	308.1K	255.6K
Total Assets	2.7B	13.7M	15.3M	968.2K	730.2K
Liabilities
Current Liabilities	412.7M	306.0K	136.0K	38.2K	35.9K
Non-Current Liabilities	1.2B	0	0	0	0
Total Liabilities	1.6B	306.0K	136.0K	38.2K	35.9K
Equity
Total Shareholders Equity	1.0B	13.4M	15.2M	930.0K	694.2K

Balance Sheet Composition

Welcure Drugs Cash Flow Statement From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Operating Activities
Net Income	27.8M	-1.7M	1.0M	235.8K	551.5K
Operating Cash Flow	-2.2B	-1.6M	1.1M	185.5K	421.9K
Investing Activities
Capital Expenditures	-170.0K	-	-	-	-
Investing Cash Flow	-635.0K	1.6M	0	-	-
Financing Activities
Dividends Paid	-	-	-	-	-
Financing Cash Flow	2.2B	-171.0K	-1.7M	-	-
Free Cash Flow	-2.2B	-1.3M	1.1M	185.5K	421.9K

Cash Flow Trend

Welcure Drugs Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 39.86

Price to Book 1.08

Price to Sales 6.58

Profitability Ratios

Profit Margin 8.84%

Operating Margin 2.97%

Return on Equity 4.18%

Return on Assets 1.29%

Financial Health

Current Ratio 4.41

Debt to Equity 120.18

Beta -1.28

Per Share Data

EPS (TTM) ₹0.36

Book Value per Share ₹13.32

Revenue per Share ₹4.07

Financial data is updated regularly. All figures are in the company's reporting currency.